Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$4.94M$4.94Mderived−62.2% vs Q4 2024 Net Income-$3.17M-$3.17MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,897,000−73.3% Operating Incomederived-$3,149,000N/M Operating Cash Flowderived-$2,207,000N/M Free Cash Flowderived-$2,365,000N/M Margins · derivedGross margin38.4%−16.0 pt vs Q4 2024
Operating margin-63.8%−77.0 pt vs Q4 2024
Net margin-64.1%−76.0 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 4, 2026 · 63 d after period end